xamoterol - CISMeF

Preferred Label : xamoterol;

MeSH definition : A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.;

MeSH hyponym : carwin; xamoterol monohydrobromide; ICI-118587; corwin; xamoterol monohydrochloride; xamoterol maleate (2:1); xamoterol hemifumarate; xamtol; ICI 118587; ICI118587; Hemifumarate, Xamoterol; Monohydrobromide, Xamoterol; Monohydrochloride, Xamoterol;

Related MeSH term : xamoterol fumarate; xamoterol, (S)-Isomer; Fumarate, Xamoterol;

MeSH CAS label : 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, ( -)-;

MeSH Related Number : xamoterol monohydrochloride; xamoterol, (S)-Isomer; xamoterol fumarate; xamoterol monohydrobromide; 81801-12-9 (Xamoterol); 90730-93-1 (Xamoterol fumarate); 112008-18-1; 112008-19-2; 69630-22-4; N87007N668;

Registry Number MeSH : 81801-12-9;

Related CAS MeSH : 112008-19-2 (Xamoterol monohydrobromide); 112008-18-1 (Xamoterol monohydrochloride); 69630-22-4 (Xamoterol, (S)-Isomer); N87007N668 (Xamoterol fumarate);

Is substance : O;

UNII : 7HE0JQL703;

InChIKey : DXPOSRCHIDYWHW-UHFFFAOYSA-N;

Details

Origin ID

D017307;

UMLS CUI

C0078595;

ATC code(s)
- xamoterol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Xamoterol [ICD-11 Extension code]
- Xamoterol [NCIt concept]
- Xamoterol (substance) [SNOMED CT concept]
Pharmacological action(s)
- adrenergic agents [MeSH Descriptor]
- adrenergic beta-1 receptor agonists [MeSH Descriptor]
Record concept(s)
- ICI-118587 [MeSH concept]
- carwin [MeSH concept]
- corwin [MeSH concept]
- xamoterol [MeSH concept]
- xamoterol fumarate [MeSH concept]
- xamoterol hemifumarate [MeSH concept]
- xamoterol maleate (2:1) [MeSH concept]
- xamoterol monohydrobromide [MeSH concept]
- xamoterol monohydrochloride [MeSH concept]
- xamoterol, (S)-Isomer [MeSH concept]
- xamtol [MeSH concept]
See also inter- (CISMeF)
- Product containing xamoterol (medicinal product) [SNOMED CT concept]
- Xamoterol adverse reaction (disorder) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing xamoterol (medicinal product) [SNOMED CT concept]
- Xamoterol [ICD-11 Extension code]
- Xamoterol [NCIt concept]
- Xamoterol (substance) [SNOMED CT concept]
- xamoterol [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients